AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease cargo in leukaemia patients

AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease cargo in leukaemia patients “Adult patients with relapsed or refractory ALL have enormously poor outcomes, with the fiveyear survival rate being less than ten percent. Therefore, there is a clear need to develop effective therapy for these patients,” said Jae Park, […]